AXL is a potential target for therapeutic intervention in breast cancer progression.
Zhang YX, Knyazev PG, Cheburkin YV, Sharma K, Knyazev YP, Orfi L, Szabadkai I, Daub H, Keri G, Ullrich A
Cancer Res. 2008 Mar 15;68(6):1905-15. doi: 10.1158/0008-5472.CAN-07-2661.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 65222 | pLXSN-Axl | Expression of Axl in mammalian cells |
| 65223 | pLXSN-Axl DN | Expression of dominant negative Axl in mammalian cells |